VanEck Pharmaceutical ETF
PPH
#1220
ETF rank
C$1.42 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
C$144.54
Share price
-0.19%
Change (1 day)
26.17%
Change (1 year)

Expense ratio and fees for VanEck Pharmaceutical ETF (PPH)

Expense Ratio

Expense Ratio as of May 2025: 0.36%

Gross Expense Ratio

Gross Expense Ratio as of April 2026: 0.36%

Net Expense Ratio

Net Expense Ratio as of April 2026: 0.36%